These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28641169)

  • 1. Association between switching antiepileptic drug products and healthcare utilization: A systematic review.
    Kwan P; Palmini A
    Epilepsy Behav; 2017 Aug; 73():166-172. PubMed ID: 28641169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy.
    Erickson SC; Le L; Ramsey SD; Solow BK; Zakharyan A; Stockl KM; Harada AS; Curtis B
    Epilepsia; 2011 Jul; 52(7):1365-71. PubMed ID: 21692778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy.
    Das S; Jiang X; Jiang W; Ting TY; Polli JE
    Epilepsy Behav; 2020 Apr; 105():106936. PubMed ID: 32092462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical consequences of generic substitution of lamotrigine for patients with epilepsy.
    LeLorier J; Duh MS; Paradis PE; Lefebvre P; Weiner J; Manjunath R; Sheehy O
    Neurology; 2008 May; 70(22 Pt 2):2179-86. PubMed ID: 18505997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
    Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
    Andermann F; Duh MS; Gosselin A; Paradis PE
    Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with seizure recurrence in epilepsy patients treated with antiepileptic monotherapy: A retrospective observational cohort study using US administrative insurance claims.
    Shcherbakova N; Rascati K; Brown C; Lawson K; Novak S; Richards KM; Yoder L
    CNS Drugs; 2014 Nov; 28(11):1047-58. PubMed ID: 25086640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L; Dae SJ
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
    Chappell B; Crawford P
    Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Antiepileptic Drug Prescriptions for Childhood Epilepsy at a Tertiary Children's Hospital in Korea, 2001-2012.
    Cho YS; Ah YM; Jung AH; Kim KJ; Lee JY
    Paediatr Drugs; 2015 Dec; 17(6):487-96. PubMed ID: 26400586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state of the union of epilepsy care in the United States: Antiepileptic drugs - An introduction to the Connectors Project.
    Sirven JI; Shafer PO; Kalilani L; Wild I; Fishman J; Owens S
    Epilepsy Behav; 2018 Mar; 80():98-103. PubMed ID: 29414565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy.
    Das S; Pu X; Jiang X; Jiang W; Tung R; Ting TY; Polli JE
    Epilepsy Behav; 2019 Jan; 90():197-203. PubMed ID: 30579779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brand-to-generic oxcarbazepine switch - A prospective observational study.
    Bosak M; Słowik A; Dziedzic T
    Epilepsy Res; 2019 Mar; 151():75-77. PubMed ID: 30836239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults.
    Hamer HM; Dodel R; Strzelczyk A; Balzer-Geldsetzer M; Reese JP; Schöffski O; Graf W; Schwab S; Knake S; Oertel WH; Rosenow F; Kostev K
    J Neurol; 2012 Nov; 259(11):2376-84. PubMed ID: 22544296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life after switching to generic levetiracetam - A prospective comparative study.
    Olsson P; Reimers A; Källén K
    Epilepsy Behav; 2019 Jul; 96():169-174. PubMed ID: 31150996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.